Role and Regulation of Pro-survival BCL-2 Proteins in Multiple Myeloma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role and Regulation of Pro-survival BCL-2 Proteins in Multiple Myeloma
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-11-20
DOI
10.3389/fonc.2018.00533
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetics of diffuse large B-cell lymphoma
- (2018) Laura Pasqualucci et al. BLOOD
- From MGUS to Multiple Myeloma, a Paradigm for Clonal Evolution of Premalignant Cells
- (2018) Niels van Nieuwenhuijzen et al. CANCER RESEARCH
- Embryogenesis and Adult Life in the Absence of Intrinsic Apoptosis Effectors BAX, BAK, and BOK
- (2018) Francine F.S. Ke et al. CELL
- T Follicular Helper Cell-Germinal Center B Cell Interaction Strength Regulates Entry into Plasma Cell or Recycling Germinal Center Cell Fate
- (2018) Wataru Ise et al. IMMUNITY
- Intrinsic Instability of BOK Enables Membrane Permeabilization in Apoptosis
- (2018) Janet H. Zheng et al. Cell Reports
- AMG 176, a Selective MCL1 Inhibitor, is Effective in Hematological Cancer Models Alone and in Combination with Established Therapies
- (2018) Sean Caenepeel et al. Cancer Discovery
- There is something about BOK we just don't get yet
- (2017) Manuel D. Haschka et al. FEBS Journal
- Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients
- (2017) V Shah et al. LEUKEMIA
- Pathways and mechanisms of venetoclax resistance
- (2017) Prithviraj Bose et al. LEUKEMIA & LYMPHOMA
- Development of venetoclax for therapy of lymphoid malignancies
- (2017) Huayuan Zhu et al. Drug Design Development and Therapy
- Hierarchy for targeting prosurvival BCL2 family proteins in multiple myeloma: pivotal role of MCL1
- (2016) J.-N. Gong et al. BLOOD
- Functional disparities among BCL-2 members in tonsillar and leukemic B-cell subsets assessed by BH3-mimetic profiling
- (2016) Victor Peperzak et al. CELL DEATH AND DIFFERENTIATION
- Mcl-1 inhibitors: a patent review
- (2016) Lijia Chen et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
- (2016) Stephan Stilgenbauer et al. LANCET ONCOLOGY
- Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models
- (2016) E. A. Punnoose et al. MOLECULAR CANCER THERAPEUTICS
- The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
- (2016) András Kotschy et al. NATURE
- MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XL
- (2016) Ingela B Vikström et al. Cell Death & Disease
- Antigen-affinity controls pre-germinal center B cell selection by promoting Mcl-1 induction through BAFF receptor signaling
- (2016) Felix M. Wensveen et al. Scientific Reports
- Pathogenesis beyond the cancer clone(s) in multiple myeloma
- (2015) G. Bianchi et al. BLOOD
- Attacking cancer's Achilles heel: antagonism of anti-apoptotic BCL-2 family members
- (2015) Joseph T. Opferman FEBS Journal
- Dexamethasone treatment promotes Bcl-2 dependence in multiple myeloma resulting in sensitivity to venetoclax
- (2015) S M Matulis et al. LEUKEMIA
- ERK1/2 has an essential role in B cell receptor- and CD40-induced signaling in an in vitro model of germinal center B cell selection
- (2015) Jemal Adem et al. MOLECULAR IMMUNOLOGY
- Low expression of pro-apoptotic Bcl-2 family proteins sets the apoptotic threshold in Waldenström macroglobulinemia
- (2015) B T Gaudette et al. ONCOGENE
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Mcl-1 Ubiquitination: Unique Regulation of an Essential Survival Protein
- (2014) Barbara Mojsa et al. Cells
- Bax Crystal Structures Reveal How BH3 Domains Activate Bax and Nucleate Its Oligomerization to Induce Apoptosis
- (2013) Peter E. Czabotar et al. CELL
- Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure
- (2013) R. L. Thomas et al. GENES & DEVELOPMENT
- The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma
- (2013) C Touzeau et al. LEUKEMIA
- Mcl-1 is essential for the survival of plasma cells
- (2013) Victor Peperzak et al. NATURE IMMUNOLOGY
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
- (2013) Peter E. Czabotar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Multiple myeloma
- (2013) D. Smith et al. BMJ-British Medical Journal
- Germinal Centers
- (2012) Gabriel D. Victora et al. Annual Review of Immunology
- Through a glass less darkly: apoptosis and the germinal center response to antigen
- (2012) Victor Peperzak et al. IMMUNOLOGICAL REVIEWS
- The establishment of the plasma cell survival niche in the bone marrow
- (2012) Van T. Chu et al. IMMUNOLOGICAL REVIEWS
- BH3-only proteins in apoptosis at a glance
- (2012) L. Happo et al. JOURNAL OF CELL SCIENCE
- Pathogenesis of follicular lymphoma
- (2012) Robert Kridel et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecular pathogenesis of chronic lymphocytic leukemia
- (2012) Gianluca Gaidano et al. JOURNAL OF CLINICAL INVESTIGATION
- MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma
- (2012) S-S Wenzel et al. LEUKEMIA
- Mcl-1 regulates the survival of adult neural precursor cells
- (2012) Craig D. Malone et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Regulation of memory B-cell survival by the BH3-only protein Puma
- (2011) C. Clybouw et al. BLOOD
- Distribution of Bim determines Mcl-1 dependence or codependence with Bcl-xL/Bcl-2 in Mcl-1-expressing myeloma cells
- (2011) A. A. Morales et al. BLOOD
- Identification of Molecular Vulnerabilities in Human Multiple Myeloma Cells by RNA Interference Lethality Screening of the Druggable Genome
- (2011) R. E. Tiedemann et al. CANCER RESEARCH
- BCL2A1: the underdog in the BCL2 family
- (2011) M Vogler CELL DEATH AND DIFFERENTIATION
- Apoptosis in cancer: from pathogenesis to treatment
- (2011) Rebecca SY Wong JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A Unified Model of Mammalian BCL-2 Protein Family Interactions at the Mitochondria
- (2011) Fabien Llambi et al. MOLECULAR CELL
- IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms
- (2010) E. De Bruyne et al. BLOOD
- BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma
- (2010) L Bodet et al. BRITISH JOURNAL OF CANCER
- Origin of Chromosomal Translocations in Lymphoid Cancer
- (2010) André Nussenzweig et al. CELL
- Germinal Center Dynamics Revealed by Multiphoton Microscopy with a Photoactivatable Fluorescent Reporter
- (2010) Gabriel D. Victora et al. CELL
- Mcl-1; the molecular regulation of protein function
- (2010) Luke W. Thomas et al. FEBS LETTERS
- Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
- (2010) Wyndham H Wilson et al. LANCET ONCOLOGY
- The role of Bcl-2 family proteins in chronic lymphocytic leukaemia
- (2010) Andrea G.S. Buggins et al. LEUKEMIA RESEARCH
- Mcl-1 Is Essential for Germinal Center Formation and B Cell Memory
- (2010) I. Vikstrom et al. SCIENCE
- Different forms of cell death induced by putative BCL2 inhibitors
- (2009) M Vogler et al. CELL DEATH AND DIFFERENTIATION
- Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
- (2009) Martin Schwickart et al. NATURE
- BH3-only proteins in apoptosis and beyond: an overview
- (2009) E Lomonosova et al. ONCOGENE
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
- Two levels of protection for the B cell genome during somatic hypermutation
- (2008) Man Liu et al. NATURE
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
- (2008) G. Lenz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now